Netcall (LON:NET) Stock Passes Below Two Hundred Day Moving Average – Should You Sell?

Netcall plc (LON:NET) shares crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 116.95 and traded as low as GBX 109. Netcall shares last traded at GBX 111.85, with a volume of 131,750 shares trading hands.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on NET shares. Berenberg Bank reiterated a “buy” rating and set a GBX 155 target price on shares of Netcall in a research report on Wednesday, October 8th. Canaccord Genuity Group lifted their price target on Netcall from GBX 130 to GBX 150 and gave the stock a “buy” rating in a research report on Wednesday, October 8th. Two research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company has an average rating of “Buy” and a consensus target price of GBX 152.50.

Netcall Trading Up 3.2%

The company has a 50 day simple moving average of GBX 115.34 and a 200 day simple moving average of GBX 116.95. The company has a current ratio of 1.22, a quick ratio of 0.88 and a debt-to-equity ratio of 1.19. The stock has a market capitalization of £190.50 million, a PE ratio of 47.30 and a beta of 0.23.

Netcall (LON:NET) last released its earnings results on Wednesday, October 8th. The company reported GBX 3.75 earnings per share (EPS) for the quarter. Netcall had a return on equity of 14.95% and a net margin of 14.99%. Analysts predict that Netcall plc will post 3.7029017 earnings per share for the current fiscal year.

About Netcall

Netcall is a UK-based enterprise software company that unites automation and customer engagement in one AI-powered platform. Its Liberty platform makes work easier by digitising processes and simplifying customer interactions in a single, easy-to-use solution that reduces complexity. Today, around 600 organisations across healthcare, government and financial services rely on Netcall for mission‑critical workflows, including two‑thirds of NHS Acute Health Trusts and major enterprises such as Legal & General, Baloise and Santander.